Study Summary
This trial is testing a lifestyle intervention to see if it's feasible and acceptable for men from South Asia and West Africa with prediabetes or diabetes. The intervention will last 16 weeks and will be focused on improving dietary and exercise habits to reduce weight.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
5 Primary · 9 Secondary · Reporting Duration: Baseline, month 4 and month 12
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Men Only
1 of 2
Dyads
1 of 2
Active Control
Experimental Treatment
48 Total Participants · 2 Treatment Groups
Primary Treatment: Intensive lifestyle interventions (ILIs) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Does this investigation still welcome new applicants?
"Affirmative. The information readily available on clinicaltrials.gov confirms that recruitment for this trial is currently in progress, with the original posting made on April 4th 2022 and a recent update following shortly after on April 18th 2022. 48 patients are being sought from 1 medical centre." - Anonymous Online Contributor
Is there a cap on the amount of participants involved in this experiment?
"Affirmative. Clinicaltrials.gov provides evidence that this medical trial is in search of participants, having been posted on April 4th 2022 and revised just recently on April 18th 2022. The requirements include 48 patients to be recruited from one particular clinic." - Anonymous Online Contributor
What are the primary goals of this medical experiment?
"The principal end point of this trial, which will be monitored at Baseline, month 4 and 12 is to assess participant preference. Auxiliary outcomes include alterations in dietary habits (measured using the REAP-S survey) as well as changes in the weight of social contacts and body mass index of participants." - Anonymous Online Contributor